Prescription Drug Affordability Board (PDAB)

PDAB Board Opening

The Prescription Drug Affordability Board is seeking applicants to fill a vacancy on the board. Applicants must be residents of Oregon and have an expertise in healthcare economics and clinical medicine. The board consists of eight members appointed by the governor and confirmed by the Senate.

Members serve four years and can seek reappointment. The time commitment is about 10 hours per month, including virtual board meetings held on the third Wednesday of the month. Submit applications in Workday by 5 p.m. on Monday, July 1, 2024. Learn more in this information letter.

2024 Generic Drug Report

The Prescription Drug Affordability Board's annual generic drug report is now available on the PDAB website. The board approved the report at the May 15 meeting. The report discusses authorized generics, generic and biosimilar litigation, legislation, pricing, and substitutions, generic formulary placement, drug shortages and generics in other countries. Find the report posted on the Legislative Reports web page.

The next PDAB meeting is:
Wednesday, July 24, 2024
9:30 A.M. Pacific Time
Register here
Meeting agenda
Agenda packet

Watch the May community forum videos

About the PDAB

The Prescription Drug Affordability Board is established in the Department of Consumer and Business Services under ORS 646A.693 to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon and others within the health care system in this state from the high costs of prescription drugs. To learn more about the board’s work, see the FAQ page.